To elucidate the molecular mechanism that underlies the POT1 downregulation-induced inhibition of cell proliferation and tumorigenicity, we evaluated the transcription levels of c-Myc, which plays a critical role in the proliferation and tumorigenicity of cancer cells [25]. The gene discussed is MYC; the disease is cancer.